PT1855661E - Formulações para aviptadil - Google Patents

Formulações para aviptadil Download PDF

Info

Publication number
PT1855661E
PT1855661E PT06707454T PT06707454T PT1855661E PT 1855661 E PT1855661 E PT 1855661E PT 06707454 T PT06707454 T PT 06707454T PT 06707454 T PT06707454 T PT 06707454T PT 1855661 E PT1855661 E PT 1855661E
Authority
PT
Portugal
Prior art keywords
aviptadil
formulation
Prior art date
Application number
PT06707454T
Other languages
English (en)
Inventor
Dorian Bevec
Gerald Bacher
Original Assignee
Mondobiotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mondobiotech Ag filed Critical Mondobiotech Ag
Publication of PT1855661E publication Critical patent/PT1855661E/pt

Links

PT06707454T 2005-03-07 2006-03-07 Formulações para aviptadil PT1855661E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005010415 2005-03-07
US66282105P 2005-03-18 2005-03-18

Publications (1)

Publication Number Publication Date
PT1855661E true PT1855661E (pt) 2011-07-05

Family

ID=43969209

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06707454T PT1855661E (pt) 2005-03-07 2006-03-07 Formulações para aviptadil

Country Status (5)

Country Link
CN (1) CN101247794B (pt)
AT (1) ATE507826T1 (pt)
DE (1) DE602006021708D1 (pt)
DK (1) DK1855661T3 (pt)
PT (1) PT1855661E (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10213485B2 (en) * 2014-09-10 2019-02-26 Kringle Pharma Inc. HGF preparation suitable for treatment of neurological disorders
CN108333360A (zh) * 2017-01-19 2018-07-27 深圳市新产业生物医学工程股份有限公司 胃泌素释放肽前体稀释液及其应用和试剂盒

Also Published As

Publication number Publication date
DE602006021708D1 (de) 2011-06-16
ATE507826T1 (de) 2011-05-15
CN101247794B (zh) 2012-02-22
DK1855661T3 (da) 2011-08-15
CN101247794A (zh) 2008-08-20

Similar Documents

Publication Publication Date Title
GB2424581B (en) Formulations
IL189856A0 (en) New formulation
PL2526930T3 (pl) Formulacja witaminowa
TWI370115B (en) New formulation
PL1879451T3 (pl) Innowacyjna formulacja
GB0518783D0 (en) Indolizine compounds
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
ZA200802602B (en) Controlled release formulation
GB0608098D0 (en) Formulation
GB0526419D0 (en) Formulation
GB0507208D0 (en) Anti-inflammatory formulation
GB0517673D0 (en) Formulation
IL185773A0 (en) Formulations
EP1928469A4 (en) Fulvestrant FORMULATION
HK1124529A1 (en) Formulation having accurate dose-dividing function
PL1855661T3 (pl) Preparaty zawierające awiptadil
EP1938808A4 (en) PREPARATION FOR TOPICAL APPLICATION
GB0423565D0 (en) Formulation
GB0412530D0 (en) Formulation
ZA200802953B (en) Solid vaccine formulation
GB0501030D0 (en) Formulation
PL1928232T3 (pl) Stała formulacja
ZA200803086B (en) Bisphosphonate formulation
PT1855661E (pt) Formulações para aviptadil
GB0500071D0 (en) Cleaning formulation